BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3002918)

  • 21. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
    J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schwangerschaftsprotein 1 (SP1) in serum and cerebrospinal fluid of patients with gestational trophoblastic disease.
    Ho PC; Ma HK
    Br J Obstet Gynaecol; 1983 Apr; 90(4):317-22. PubMed ID: 6188478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serum pregnancy-specific beta 1-glycoprotein to beta-human chorionic gonadotrophin ratio as an index of prognosis in patients with choriocarcinoma.
    Sakuragi N; Ohkubo H; Yamamoto R; Shiina Y; Tanaka T; Ichinoe K; Fujimoto S
    Br J Obstet Gynaecol; 1988 Jun; 95(6):614-8. PubMed ID: 2455537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
    Huang SC; Hsieh CY; Ouyang PC
    J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and radiological features of gestational trophoblastic tumors].
    Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
    Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern management of gestational trophoblastic disease.
    McDonald TW; Ruffolo EH
    Obstet Gynecol Surv; 1983 Feb; 38(2):67-83. PubMed ID: 6300738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.
    Kohorn EI
    Obstet Gynecol; 1982 Jan; 59(1):78-84. PubMed ID: 6281702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management.
    Goldstein DP; Berkowitz RS
    Major Probl Obstet Gynecol; 1982; 14():1-301. PubMed ID: 6273659
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant gestational trophoblastic disease.
    Lifshitz S; Outhouse C; Buchsbaum HJ
    J Iowa Med Soc; 1977 Oct; 67(10):391-5. PubMed ID: 198497
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of concanavalin A-unbound serum pregnancy-specific beta 1-glycoprotein in the assessment of trophoblastic diseases.
    Englebienne P; Doyen G
    Ric Clin Lab; 1984; 14(3):561-3. PubMed ID: 6098001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnosis and treatment of trophoblastic uterine tumors].
    Kozachenko VP; Toloknov BO; Savinova VF; Grigorova TM
    Vopr Onkol; 1982; 28(5):97-103. PubMed ID: 6283736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.